Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Discovery"
DOI: 10.1158/2159-8290.cd-22-0966
Abstract: Metastatic relapse after treatment is the leading cause of cancer mortality, and known resistance mechanisms are missing for most treatments administered to patients. To bridge this gap, we analyze a pan-cancer cohort (META-PRISM) of 1,031… read more here.
Keywords: cancer; refractory metastatic; pan cancer; resistance ... See more keywords